# Filing Detail

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001554855-25-002032
Filing Date
2025-11-13
Accepted
2025-11-13 13:31:01
Documents
68
Period of Report
2025-09-30

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 10-Q | sxtp-20250930.htm iXBRL | 10-Q | 2084993
7 | EXHIBIT 31.1 | ex311_1.htm | EX-31.1 | 13766
8 | EXHIBIT 31.2 | ex312_2.htm | EX-31.2 | 13595
9 | EXHIBIT 32.1 | ex321_3.htm | EX-32.1 | 5679
10 | EXHIBIT 32.2 | ex322_4.htm | EX-32.2 | 5483
| Complete submission text file | 0001554855-25-002032.txt |  | 9353983

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
2 | DEFINITION | sxtp-20250930_def.xml | EX-101.DEF | 333126
3 | PRESENTATION | sxtp-20250930_pre.xml | EX-101.PRE | 499621
4 | CALCULATION | sxtp-20250930_cal.xml | EX-101.CAL | 87023
5 | LABEL | sxtp-20250930_lab.xml | EX-101.LAB | 954738
6 | SCHEMA | sxtp-20250930.xsd | EX-101.SCH | 66784
71 | EXTRACTED XBRL INSTANCE DOCUMENT | sxtp-20250930_htm.xml | XML | 1379962

Mailing Address 1025 CONNECTICUT AVENUE NW SUITE 1000 WASHINGTON DC 20036
Business Address 1025 CONNECTICUT AVENUE NW SUITE 1000 WASHINGTON DC 20036 202-327-5422
60 DEGREES PHARMACEUTICALS, INC. (Filer) CIK: 0001946563 (see all company filings)

EIN.: 452406880 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-41719 | Film No.: 251477100
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)